BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• BioMidwest

  Vansen Pharma Commences Trading Under New Symbol “VNSN”

  September 30, 2013

   · 

  1 min read
• Deals

  Orthobiotiki Holdings Acquires Exclusive Distribution Rights of Celergen for Greece and Cyprus

  September 30, 2013

   · 

  1 min read
• Genetown

  OmniGuide Introduces ELEVATE™ ENT System

  September 30, 2013

   · 

  1 min read
• Antisense Pharma Changes Name to Isarna Therapeutics

  September 30, 2013

   · 

  2 min read
• Lone Star Bio

  Moleculin Reports Positive Data From Controlled Study of Novel Topical Psoriasis Treatment

  September 30, 2013

   · 

  2 min read
• Business

  Activiomics Extends Capability to Clinical Biomarker Discovery and Appoints CEO

  September 30, 2013

   · 

  3 min read
• Deals

  Verdesian Life Sciences Acquires INTX Microbials

  September 30, 2013

   · 

  4 min read
• Multiplicom Launches Three New Mutation Detection Kits to Enable the Implementation of Personalized Cancer Treatment

  September 30, 2013

   · 

  3 min read
• Pharm Country

  New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015

  September 30, 2013

   · 

  3 min read
• FDA

  FDA Approves New Dosing Option for CSL Behring’s Hizentra®

  September 30, 2013

   · 

  6 min read